PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical - PowerPoint PPT Presentation

Jan 03, 2024 •143 likes •334 views

PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical Forum General Director, CV Protek Adam Smith Conferences,16th May 20, 2010 IMPORTANT NOTICE (Disclaimer) This presentation has been prepared by OJSC Protek (the

PHARMA, FORWARD! Speaker: Aleksey Molchanov, Russian Pharmaceutical Forum General Director, CV Protek Adam Smith Conferences,16th May 20, 2010

Recommend

Pharma Resources Come in and get to know Pharma Resources. We appreciate your interest. Welcome

Pharma Resources Come in and get to know Pharma Resources. We appreciate your interest. Welcome to Pharma Resources For over 20 years we assist and support our customers in the healthcare industry in bringing pharmaceuticals and medical devices

1.04k views • 18 slides

Springer for R&D Pharma Springer for R&D Pharma Springer for R&D

Springer for R&D Pharma Springer for R&D Pharma Springer for R&D rd.springer.com Immediate Access to Quality STM Research Thousands of eBooks, Journals and eReference Works on one platform Customized collections for

245 views • 12 slides

PENTA-ID and Pharma collaborations Enpr-EMA 2013 PENTA-ID and Pharma collaboration

PENTA-ID and Pharma collaborations Enpr-EMA 2013 PENTA-ID and Pharma collaboration Complex and wide ranging interactions Working with SME and large Pharma Phase I, II, III, IV Many good examples of collaborative

281 views • 12 slides

Pharma Strategies for a New Reimbursement Environment New York Pharma Forum March 26, 2012

Pharma Strategies for a New Reimbursement Environment New York Pharma Forum March 26, 2012 Roger Longman roger.longman@realendpoints.com 1 Pharma business model under threat as R&D less likely to drive value If cost of extracting coal

420 views • 23 slides

About United Pharma Canada United Pharma is a modern Canadian manufacturing company , specialized

About United Pharma Canada United Pharma is a modern Canadian manufacturing company , specialized in manufacturing Pharmaceutical, Nutraceuticals andCosmeceuticalproducts that adopt new technology . Currently , the aim of United Pharma is to

433 views • 41 slides

Pharma Innovation a Pharma Inno tion at K Korea - Business Oppor usiness Opportunities in K

Pharma Innovation a Pharma Inno tion at K Korea - Business Oppor usiness Opportunities in K unities in Korea a - October 23, 2014 Dahee JEONG Director of Bio-Medical Industry, Investment Promotion Department Invest Korea , KOTRA

1.03k views • 55 slides

Synact Pharma AB A new medicine to treat inflammatory diseases Jeppe vlesen, MBA Thomas

Synact Pharma AB A new medicine to treat inflammatory diseases Jeppe vlesen, MBA Thomas Jonassen, MD CEO CSO Sedermera Dagen Copenhagen, March 13, 2018 SYNACT PHARMA OVERVIEW Synact Pharma AB listed at Aktietorget in July 2016

628 views • 15 slides

WHERE IS INDIAN PHARMA HEADED? Motilal Oswal 2017 Conference Nilesh Gupta Managing Director

WHERE IS INDIAN PHARMA HEADED? Motilal Oswal 2017 Conference Nilesh Gupta Managing Director Lupin Ltd. September 2017 IS THE INDIAN PHARMA DREAM RUN OVER? Pharma Company Growth and Returns Indian Pharma Company Growth Indian Pharma

588 views • 45 slides

Presentation of the label Certicold PHARMA Sommaire 1. Pharmaceutical context 2. The

Presentation of the label Certicold PHARMA Sommaire 1. Pharmaceutical context 2. The Certicold Pharma Solution 3. The labelled products 4. Why choose Certicold Pharma? 5. Mode of labelling 6. Who is issuing the label? 1

686 views • 24 slides

Vistin Pharma Corporate Presentation October 2016 Content Introduction to Vistin Pharma

Vistin Pharma Corporate Presentation October 2016 Content Introduction to Vistin Pharma Operational and financial update Summary & outlook Appendix Snapshot Vistin at a glance Summary Presence in c.40 countries Established in June

779 views • 22 slides

Airport Infrastructure Development A Cargo Pharma SCL Indonesia 2018 Shangri La, Jakarta PT.

Airport Infrastructure Development A Cargo Pharma SCL Indonesia 2018 Shangri La, Jakarta PT. Angkasa Pura II Group [1] Facts & Figures Pharma Industry [2] IATA Pharma Standardization [3] Infrastructure Development at Airport [3] Index

490 views • 31 slides

The Artificially Intelligent Pharma & Healthcare Sector M. Morris Hosseini, MSc, PhD

The Artificially Intelligent Pharma & Healthcare Sector M. Morris Hosseini, MSc, PhD Senior Partner CC Pharma & Healthcare Roland Berger Grand Hyatt Athens, September 24 th 2018 What are the therapies of the future in the digital

540 views • 21 slides

2018 Pricing Reform: Will Takeda Exit the Japanese Pharma Market? Japan Pharma & Governance

2018 Pricing Reform: Will Takeda Exit the Japanese Pharma Market? Japan Pharma & Governance Tour: UBS Securities e-Projection K.K. July 12, 2018 e-Projection Three Forces Determining the Direction of Healthcare Shape of the market will

399 views • 7 slides

Attributes of Pharma Biotech Patenting a European Perspective a European Perspective Szeged May

Gedeon Richter Pharma GmbH, BioIP Department Attributes of Pharma Biotech Patenting a European Perspective a European Perspective Szeged May 11, 2012 Walter Hinderer 1 Attributes of Pharma Biotech Patenting > Agenda Agenda [Slide No.]:

258 views • 24 slides

New York Pharma Forum NIF Ventures JUNE 23, 2005 Goro Takeda New York Pharma Forum June 23,

New York Pharma Forum NIF Ventures JUNE 23, 2005 Goro Takeda New York Pharma Forum June 23, 2005 CONFIDENTIAL NIF Ventures At a Glance Global VC Firm with Over 20 Years of Operational History Founded in 1982 $1.4B under management

511 views • 37 slides

NuvOx Pharma Oxygen Nanotechnology Platform Cancer and Other

NuvOx Pharma Oxygen Nanotechnology Platform Cancer and Other Life Threatening Conditions NuvOx Pharma, LLC, 1635 E. 18 th St., Tucson, AZ, 85719

340 views • 23 slides

Aurobindo Pharma Limited Q1FY21 Earnings Presentation 12 th August 2020 Aurobindo Pharma Limited

Aurobindo Pharma Limited Q1FY21 Earnings Presentation 12 th August 2020 Aurobindo Pharma Limited Earnings Presentation 2 Disclaimer This presentation is provided for informational purposes only and does not constitute or form part of any

517 views • 17 slides

Aurobindo Pharma Limited Q3FY20 Earnings Presentation 6 th February 2020 Aurobindo Pharma Limited

Aurobindo Pharma Limited Q3FY20 Earnings Presentation 6 th February 2020 Aurobindo Pharma Limited Earnings Presentation 2 Disclaimer This presentation is provided for informational purposes only and does not constitute or form part of any

539 views • 16 slides

Aurobindo Pharma Limited Q4FY20 & FY20 Earnings Presentation 3 rd June 2020 Aurobindo Pharma

Aurobindo Pharma Limited Q4FY20 & FY20 Earnings Presentation 3 rd June 2020 Aurobindo Pharma Limited Earnings Presentation 2 Disclaimer This presentation is provided for informational purposes only and does not constitute or form part of

645 views • 20 slides

FUTURE IN SOUTH FLORIDA FEBRUARY 3, 2016 Thank you to our Sponsors MIA PHARMA HUB Economic

THE STATE OF PHARMA AND ITS FUTURE IN SOUTH FLORIDA FEBRUARY 3, 2016 Thank you to our Sponsors MIA PHARMA HUB Economic Powerhouse Industry Leader International Brand Jimmy Nares February 3, 2016 Section Chief, Marketing Division, MDAD

554 views • 28 slides

New York Pharma Forum General Assembly Innovation and R&D Commoditization of pharmaceutical

New York Pharma Forum General Assembly Innovation and R&D Commoditization of pharmaceutical December 4, 2009 Dr. Hatsuo Aoki, Ph. D. Senior Advisor, Astellas Pharma Inc. Drugs Therapeutic Effect vs. Therapeutic Satisfaction 100%

813 views • 56 slides

VICORE PHARMA AB Untangling the Dualistic Components of the RAS in PF the Yin and Yang Dr Rohit

VICORE PHARMA AB Untangling the Dualistic Components of the RAS in PF the Yin and Yang Dr Rohit Batta Chief Medical Officer Vicore Pharma Vicore at a glance FOCUS Patients with fibrotic lung disease GUIDING Unmet medical needs

1.03k views • 18 slides

Prospective Workshop Essec Sant Centrale Sant Will the Pharma bubble collapse

Prospective Workshop Essec Sant Centrale Sant Will the Pharma bubble collapse within 3 years? Why payers reimbursement strategies should have a significant impact on the Pharma research paradigm? Caroline Conti, Senior

788 views • 9 slides

Novel antiviral drug products and technologies 1 1 Forward-Looking Statement This presentation

Cocrystal Pharma, Inc. Novel antiviral drug products and technologies 1 1 Forward-Looking Statement This presentation contains forward-looking statements. These forward- looking statements are subject to risks and uncertainties, including the

380 views • 25 slides